Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
Clinical trial NCT00105976 · COMPLETED
Trial details
- NCT number
- NCT00105976
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.